Breadcrumb

  1. Our vision
  2. About Santen
  3. Santen facts and figures

Santen facts and figures

€1.9 billion

€1.9 billion revenue
(approx. 249.6 billion yen)

94% of revenue from prescription ophthalmic pharmaceuticals

94% of revenue from prescription ophthalmic pharmaceuticals 

Overseas sales accounts for 32%

Sales outside Japan account for 32% of corporate revenue

4,229 employees globally

4,229 employees globally

Products supplied in over 60 countries

Products supplied in over 60 countries 

Dedicated facility for ongoing research and development

Dedicated facilities for ongoing research and development: Nara (Japan), Evry (France), Emeryville (US)

Three manufacturing sites

Three manufacturing sites: Noto and Shiga (Japan), Suzhou (China)

Source: Santen Pharmaceutical Co., Ltd. Fiscal year (FY2020) ended 31 March 2021.